Tabernanthalog
Appearance
Names | |
---|---|
IUPAC name
8-methoxy-3-methyl-2,4,5,6-tetrahydro-1H-azepino[4,5-b]indol
| |
Identifiers | |
3D model (JSmol)
|
|
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C14H18N2O | |
Molar mass | 230.311 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Tabernanthalog is a water-soluble, non-toxic analog of the psychoactive drug ibogaine first synthesized by Professor David E Olson.[1]
In rodents, it was found to promote structural neural plasticity, reduce drug seeking behaviour, and produce antidepressant like effects.[1][2]
See also
References
- ^ a b Cameron, Lindsay P.; Tombari, Robert J.; Lu, Ju; Pell, Alexander J.; Hurley, Zefan Q.; Ehinger, Yann; Vargas, Maxemiliano V.; McCarroll, Matthew N.; Taylor, Jack C.; Myers-Turnbull, Douglas; Liu, Taohui (9 Dec 2020). "A non-hallucinogenic psychedelic analogue with therapeutic potential". Nature. 589 (7842): 474–479. doi:10.1038/s41586-020-3008-z. ISSN 1476-4687. PMC 7874389. PMID 33299186.
- Andy Fell (December 9, 2020). "New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression".
- ^ Peters, Jamie; Olson, David E (2021-07-20). "Engineering Safer Psychedelics for Treating Addiction". Neuroscience Insights. 16: 263310552110338. doi:10.1177/26331055211033847. ISSN 2633-1055. PMC 8295933. PMID 34350400.